BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37951548)

  • 1. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
    Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the utilization of brachytherapy in cervical cancer in the United States.
    Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
    Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of vaginal brachytherapy to external beam radiotherapy in adjuvant therapy for high-risk early-stage cervical cancer: A comparative study.
    Ragab OM; Mehta S; Nusbaum DJ; Shimada M; Brunette LL; Roman LD; Matsuo K
    Brachytherapy; 2022; 21(2):141-150. PubMed ID: 34756697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
    Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis.
    Rao YJ; Hui C; Chundury A; Schwarz JK; DeWees T; Powell MA; Mutch DG; Grigsby PW
    Brachytherapy; 2017; 16(4):831-840. PubMed ID: 28533162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
    Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

  • 12. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
    Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study.
    Patel MK; Cote ML; Ali-Fehmi R; Buekers T; Munkarah AR; Elshaikh MA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):178-84. PubMed ID: 22014953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
    Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
    Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.
    Lu DJ; Atkins KM; Small W; Kamrava M
    Brachytherapy; 2022; 21(1):22-28. PubMed ID: 34895839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea.
    Kim YA; Yang MS; Park M; Choi MG; Kim SY; Kim YJ
    J Gynecol Oncol; 2021 Nov; 32(6):e85. PubMed ID: 34431256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.
    Boyce-Fappiano D; Nguyen KA; Gjyshi O; Manzar G; Abana CO; Klopp AH; Kamrava M; Orio PF; Thaker NG; Mourtada F; Venkat P; Chang AJ
    JCO Oncol Pract; 2021 Dec; 17(12):e1958-e1967. PubMed ID: 34550749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.